Detalhe da pesquisa
1.
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR.
Blood
; 140(5): 451-463, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605184
2.
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
Clin Trials
; 21(2): 189-198, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877369
3.
Selumetinib in Children with Inoperable Plexiform Neurofibromas.
N Engl J Med
; 382(15): 1430-1442, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187457
4.
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Blood
; 138(24): 2469-2484, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525183
5.
Identification of essential genes for cancer immunotherapy.
Nature
; 548(7669): 537-542, 2017 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28783722
6.
Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.
Br J Haematol
; 196(1): 169-178, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580862
7.
A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
Oncologist
; 27(3): 198-209, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274710
8.
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.
Oncologist
; 27(3): e273-e285, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274717
9.
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Rheumatology (Oxford)
; 61(8): 3317-3328, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875023
10.
A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas.
Future Oncol
; 18(20): 2475-2481, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535581
11.
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Proc Natl Acad Sci U S A
; 116(18): 9008-9013, 2019 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975761
12.
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
Oncologist
; 26(4): 288-e541, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33554406
13.
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
Oncologist
; 26(5): e847-e858, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594772
14.
Viral, immunologic, and clinical features of primary effusion lymphoma.
Blood
; 133(16): 1753-1761, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782610
15.
Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma.
Invest New Drugs
; 39(3): 821-828, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405090
16.
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
BJU Int
; 127(4): 435-444, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969563
17.
Evaluation of Factors Associated With Successful Matriculation to Colon and Rectal Surgery Fellowship.
Dis Colon Rectum
; 64(2): 234-240, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315718
18.
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Lancet Oncol
; 21(8): 1099-1109, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645282
19.
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
; 26(1): 94-106, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493539
20.
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin.
Cancer
; 126(22): 4936-4947, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32870522